GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain
Yoon, J W, Liu, C Z, Yang, J T, Swart, R, Iannaccone, P, Walterhouse, D
Published in The Journal of biological chemistry (06.02.1998)
Published in The Journal of biological chemistry (06.02.1998)
Get full text
Journal Article
Abstract PS11-32: Mario-3 phase II study safety run-in evaluating a novel triplet combination of eganelisib (formerly IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)
Hamilton, Erika, Lee, Arielle, Swart, Rachel, Newton, Gina, O'Connell, Brenda, Roberts, Jennifer, Zhang, Halle, Soliman, Hatem
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)
Hatem, Soliman, Hargis, Jeffrey, Elias, Anthony, Lee, Arielle, Swart, Rachel, Dahkil, Shaker, Drakaki, Alexandra, Phan, Vu, Kass, Frederic, Cobleigh, Melody, Babu, Sanil, Tkaczuk, Katherine, O'Connell, Brenda, Roberts, Jennifer, Zizlsperger, Nora, Hamilton, Erika
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
Mahadevan, Daruka, Theiss, Noah, Morales, Carla, Stejskal, Amy E, Cooke, Laurence S, Zhu, Min, Kurtzman, Drew, Swart, Rachel, Ong, Evan, Qi, Wenqing
Published in Oncotarget (10.02.2015)
Published in Oncotarget (10.02.2015)
Get full text
Journal Article
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Mahadevan, Daruka, Sutton, Gregory Ryan, Arteta-Bulos, Rafael, Bowden, Chris J., Miller, Paul J. E., Swart, Rachel Elizabeth, Walker, Mark S., Haluska, Paul, Munster, Pamela N., Marshall, John, Hamid, Omid, Kurzrock, Razelle
Published in Cancer chemotherapy and pharmacology (01.03.2014)
Published in Cancer chemotherapy and pharmacology (01.03.2014)
Get full text
Journal Article
Phase Ib study of open-label AMG 386 plus paclitaxel (P) and trastuzumab (T) or capecitabine (C) and lapatinib (L) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC)
Wildiers, Hans, Goncalves, Anthony, Kemeny, Margaret, Swart, Rachel Elizabeth, Freyer, Gilles, Nanayakkara, Nuwan, Wu, Benjamin, Pickett-Gies, Cheryl Ann, Kaufman, Peter Andrew
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase Ib study of safety, tolerability, and efficacy of R1507 a monoclonal antibody to IGF-1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies
Mahadevan, Daruka, Sutton, Gregory Ryan, Arteta-Bulos, Rafael, Bowden, Chris J., Miller, Paul J. E., Swart, Rachel Elizabeth, Walker, Mark S., Munster, Pamela N., Dees, Elizabeth Claire, Marshall, John, Hamid, Omid, Kurzrock, Razelle
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Pentostatin and Alemtuzumab: An Immunosuppressive Nonmyeloablative Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
Anwer, Faiz, Carroll, Michael P., Green, Myke R., Cranmer, Lee, Downey, Leona, Garland, Linda, Moini, Katayoun, Persky, Daniel O., Swart, Rachel, Yeager, Andrew M.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article